HKU Establishes a Stem Cell Based Model for Identification of
Novel DNA Changes in Patients with Hirschsprung Disease
05 Apr 2017
Hirschsprung (HSCR) disease (congenital megacolon) is a birth defect affecting the motility of the bowel. These babies suffer from severe constipation and intestinal obstruction because the nerve cells which co-ordinate bowel movements are absent. It is a global problem but is particularly prevalent in Asia, affecting 1 in 3,000 babies. It is known that DNA changes disrupting the function of RET gene cause a severe form of HSCR disease (total colonic aganglionosis). However, 80% of HSCR patients have short-segment HSCR disease (S-HSCR), which has not been associated with genetic factors.
Li Ka Shing Faculty of Medicine, The University of Hong Kong (HKU) has created a stem cell-based disease model of HSCR for discovery of novel DNA changes that contribute to disease phenotypes. With the stem cell-based disease model of HSCR and the next-generation sequencing technologies, the study identified that a specific DNA change in vinculin (VCL) gene disrupts the migration and differentiation of neural stem cells of the bowel, leading to malformation of enteric nervous system as seen in HSCR patients. The newly developed stem cell-based disease model provides a powerful platform for studying the heterogeneous phenotypes of the diseases and that represents an important step toward personalised treatment. The research has just been published in Gastroenterology, the top journal in the field of Gastroenterology.
Leading researcher of the study, Dr Elly Ngan Sau-wai, Associate Professor of the Department of Surgery, Li Ka Shing Faculty of Medicine, HKU remarks, “Disease relevant cells can be generated using patient-specific stem cells which carry the same genetic background as of the patient. Using the disease relevant patient cells in biomedical research will help address how genetic background may affect the disease phenotypes, paving a way to develop personalised medicine.”
About Hirschsprung (HSCR) disease
Babies born with HSCR disease will die unless the portion of the bowel with no nerve cells is surgically removed. In Hong Kong, over 120 affected babies have been operated in the last ten years. Nevertheless, the functional outcome of surgery is variable and a significant number of patients still suffer from life-long complications, ranging from intractable constipation, incontinence, enterocolitis to devastating short bowel syndrome, leading to not only tremendous psychosocial impact on the patients, but also a heavy financial burden to the health care system.
HSCR disease is attributed to a failure in formation of nerve cells in the intestine. During development, neural stem cells in the bowel (enteric neural crest cells, ENCCs) need to migrate a long way to fully colonise the entire bowel. ENCCs also undergo differentiation to give rise to a wide-range of nerve cells, which subsequently form a neural network to control the bowel movement. The migration and differentiation of ENCCs have to be precisely regulated, in order to establish a functional network for the bowel. DNA changes in the genes implicated in these two processes may disturb the formation of functional neural network, leading to HSCR disease.
Based on the previous findings published in 2009-2015, the HKU research team further established a human stem cell-based disease model for identification of novel disease-associated DNA changes, and elucidating how these DNA changes cause HSCR disease. The team has established numerous “diseased” induced pluripotent stem cells (iPSC) lines by (1) reprogramming fibroblast cells from 1 patient with total colonic aganglionosis (with a DNA change in RET) and from 2 patients with S-HSCR (without DNA change in RET); and (2) introducing RET mutations (HSCR-associated DNA changes) into a healthy control iPSC. The disease relevant cells (ENCCs) were generated from the “diseased” and healthy control iPSC lines. Migration and differentiation capacities of iPSC-derived ENCCs were analysed in differentiation and migration assays.
The study revealed that ENCCs derived from all “diseased” iPSC lines, but not healthy control iPSCs, had defects in migration and neuronal lineage differentiation. RET mutations were associated with differentiation and migration defects of ENCCs in vitro. To further discover novel DNA changes associated with S-HSCR, the team used the next-generation sequencing technologies to correlate the DNA changes with the changes in the expression profile of the patient iPSC derived ENCCs. The team successfully associated a DNA change in the vinculin gene (VCL M209L) with S-HSCR. Using the latest genome-editing technology (CRISPR/Cas9), the HSCR-associated DNA changes (RET G731del and VCL M209L mutations) were corrected in iPSCs. These corrections restored the differentiation and migration capacities of ENCCs.
Collectively, HKU researchers have identified DNA change in VCL associated with S-HSCR. Correction of this mutation in iPSC using CRISPR/Cas9 editing, as well as the RET G731del mutation that causes HSCR disease with total colonic aganglionosis, restored ENCC function. The current study demonstrates how human stem cells can be used to identify disease-associated DNA changes and determine how they affect cell functions and contribute to pathogenesis.
Previous study results
In the last decade, the HKU research team has conducted various genetic and functional studies to explore the genetic basis of HSCR. The first whole genome genetic screen was conducted on 200 patients with HSCR and 408 healthy individuals to identify the susceptibility genes for HSCR disease. The work was published in Proceedings of the National Academy of Sciences in 2009. Subsequently, the team employed another sophisticated computational and statistics methods to identify a discrete number of genes which interact with each other to cause HSCR disease. With the mouse models, the study identified that specific DNA changes in Patched (PTCH1) and Delta-like 3 (DLL3) genes will lead to premature development of nerve-supporting cells, thus increase the risk of having HSCR by 278%. The research was published in Journal of Clinical Investigation in 2011, the top journal in the field of developmental biology. In 2015, the team identified several novel GLI mutations in HSCR patients. With the mouse models, the study directly demonstrated for the first time the coordination of SUFU-GLI-SOX10 gene in formation of nerve cells and nerve-supporting cells in the bowel and that its perturbation leads to HSCR. The findings were published in Gastroenterology in 2015.
About the HKU research team
This study was led by Dr Elly Ngan Sau-wai, Associate Professor of Department of Surgery, Li Ka Shing Faculty of Medicine, HKU. The human stem cell studies were performed by Dr Frank Lai Pui-ling and Dr Cynthia Lau Sin-ting, Post-doctoral Fellows of Department of Surgery. Genetic and bioinformatics analysis was performed in collaboration with Dr Maria-Mercedes Garcia-Barcelo, Associate Professor of Department of Surgery, Professor Paul Tam Kwong-hang, Li Shu-Pui Professor in Surgery and Chair Professor of Paediatric Surgery of Department of Surgery, Dr John Wong Kwong-leong and Dr Gui Hong-sheng, Post-doctoral Fellows of Department of Psychiatry. Other researchers include Professor Tse Hung-fat, William M W Mong Professor in Cardiology and Chair Professor of Cardiovascular Medicine of Department of Medicine, Dr Kevin Lai Wing-hon, Senior Technical Officer of Department of Medicine; Mr Reeson Wang Xu and Miss Zhou Tingwen, PhD students of Department of Surgery, Li Ka Shing Faculty of Medicine, HKU.
This work was supported by research grants (HKU17119514 and T12C-714/14-R) from the Research Grants Council and the Health and Medical Research Fund (HMRF) (01121476) from the Department of Health.
To use the press release photo(s) for any publishing, publicity and related purpose, photo courtesy should be given to “Li Ka Shing Faculty of Medicine, The University of Hong Kong”.